Literature DB >> 10490198

Lobular carcinoma in situ: current concepts and controversies.

S J Schnitt1, M Morrow.   

Abstract

Clinical and clinicopathologic studies performed over the last 50 years have elucidated many of the important features of lobular carcinoma in situ. However, certain aspects of the natural history, treatment, and diagnosis of these lesions remain controversial. The purpose of this article is to review the current understanding of lobular carcinoma in situ and to highlight some of the controversies surrounding this entity.

Entities:  

Mesh:

Year:  1999        PMID: 10490198

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  11 in total

1.  The impact of large sections and 3D technique on the study of lobular in situ and invasive carcinoma of the breast.

Authors:  Maria P Foschini; Alberto Righi; Maria C Cucchi; Teresa Ragazzini; Stefano Merelli; Bruna Santeramo; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2005-12-03       Impact factor: 4.064

2.  [Concepts and problems of lobular neoplasia].

Authors:  H P Sinn; B Helmchen; S Aulmann
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

3.  Molecular classification of breast carcinoma in situ.

Authors:  Usha Raju; Lu Mei; Sethi Seema; Qureshi Hina; Sandra R Wolman; Maria J Worsham
Journal:  Curr Genomics       Date:  2006       Impact factor: 2.236

Review 4.  American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.

Authors:  Stuart J Schnitt; Edi Brogi; Yunn-Yi Chen; Tari A King; Sunil R Lakhani
Journal:  Ann Diagn Pathol       Date:  2020-02-15       Impact factor: 2.090

5.  Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.

Authors:  Yunn-Yi Chen; Eun-Sil Shelley Hwang; Ritu Roy; Sandy DeVries; Joseph Anderson; Chrystal Wa; Patrick L Fitzgibbons; Timothy W Jacobs; Gaetan MacGrogan; Hans Peterse; Anne Vincent-Salomon; Taku Tokuyasu; Stuart J Schnitt; Frederic M Waldman
Journal:  Am J Surg Pathol       Date:  2009-11       Impact factor: 6.394

6.  Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue.

Authors:  Dung-Tsa Chen; Aejaz Nasir; Aedin Culhane; Chinnambally Venkataramu; William Fulp; Renee Rubio; Tao Wang; Deepak Agrawal; Susan M McCarthy; Mike Gruidl; Gregory Bloom; Tove Anderson; Joe White; John Quackenbush; Timothy Yeatman
Journal:  Breast Cancer Res Treat       Date:  2009-03-06       Impact factor: 4.872

7.  E-cadherin expression: a diagnostic utility for differentiating breast carcinomas with ductal and lobular morphologies.

Authors:  Kanthilatha Pai; Poornima Baliga; Bishwo Lal Shrestha
Journal:  J Clin Diagn Res       Date:  2013-03-18

8.  Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern.

Authors:  Douglas S Gomes; Simone S Porto; Rafael M Rocha; Helenice Gobbi
Journal:  Diagn Pathol       Date:  2013-07-09       Impact factor: 2.644

9.  Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.

Authors:  Dengfeng Cao; Kornelia Polyak; Marc K Halushka; Hind Nassar; Nina Kouprina; Christine Iacobuzio-Donahue; Xinyan Wu; Saraswati Sukumar; Jessica Hicks; Angelo De Marzo; Pedram Argani
Journal:  Breast Cancer Res       Date:  2008-10-27       Impact factor: 6.466

Review 10.  Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance.

Authors:  Jaafar Makki
Journal:  Clin Med Insights Pathol       Date:  2015-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.